(Stroke. 1999;30:1033-1037.)
© 1999 American Heart Association, Inc.
Original Contributions |
Effect of Thrombin Inhibition in Vascular Dementia and Silent Cerebrovascular Disease
An MR Spectroscopy Study
From the Department of Cardiology, Jichi Medical School, Tochigi, Japan (K.K., S.H., Y.U., K.S.); Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Hyogo, Japan (T.M.); and Cardiovascular Center, The New York Hospital/Cornell University Medical College, New York, NY (K.K.). Correspondence to Dr Kazuomi Kario, MD, PhD, Hypertension Center, The New York Hospital/Cornell University Medical College, 1300 E York Ave, New York, NY 10021.
Background and Purpose—Silent cerebrovascular disease (CVD) has been proposed as a predisposing condition for clinically overt stroke and vascular dementia. Recently, we found increased thrombin generation in silent CVD patients. Here, we report the effect of thrombin inhibition using a potent selective thrombin inhibitor on the cerebral metabolism and function in peripheral arterial occlusive disease (PAOD) patients with or without silent CVD.
Methods—We examined 17 mild chronic PAOD patients, including 2 cases of vascular dementia. We divided the patients into 2 groups: 1 was the advanced CVD group with multiple lacunar infarction and/or advanced periventricular hyperintensity detected by brain MRI (n=12), and the other was the no CVD group that had none of these abnormalities (n=5). We assessed the cerebral biochemical compounds in the deep white matter area and cerebellar hemisphere (8 cm3) by proton MR spectroscopy before and after infusion of argatroban (10 mg/d IV) over 2 hours for 7 days.
Results—The ratio of N-acetylasparate (NAA) to total creatine (Cre) in the deep white matter area was significantly lower in the advanced CVD group than in the no CVD group, whereas there were no significant differences in this ratio in the cerebellar hemisphere between the 2 groups. In the former group, this decreased NAA/Cre ratio significantly increased after argatroban therapy, whereas there was no change in the latter group. The 2 patients with vascular dementia showed clinical improvement with marked increases in the NAA/Cre ratio and mini-mental score.
Conclusions—These results suggest that increased thrombin generation may have some pathophysiological roles in developing vascular dementia and its chronic predisposing conditions. Thrombin inhibition may break this vicious cycle and lead to clinical improvement.
Key Words: cerebral metabolism • cerebrovascular disorders • dementia, vascular • spectroscopy, nuclear magnetic resonance • thrombin
This article has been cited by other articles:
 |
|
 |
|
  R. A. Mangiafico, F. Sarnataro, M. Mangiafico, and C. E. Fiore Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels Age Ageing, January 1, 2006; 35(1): 60 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kario, J. Ishikawa, S. Hoshide, Y. Matsui, M. Morinari, K. Eguchi, S. Ishikawa, and K. Shimada Diabetic Brain Damage in Hypertension: Role of Renin-Angiotensin System Hypertension, May 1, 2005; 45(5): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. R. Walker and D. Royston Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies Br. J. Anaesth., June 1, 2002; 88(6): 848 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tomimoto, I. Akiguchi, R. Ohtani, H. Yagi, M. Kanda, H. Shibasaki, and Y. Yamamoto The Coagulation-Fibrinolysis System in Patients With Leukoaraiosis and Binswanger Disease Arch Neurol, October 1, 2001; 58(10): 1620 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]
|
|